Contrast-enhanced ultrasound imaging of antiangiogenic tumor therapy
Anti-angiogenic treatment is a promising strategy for cancer therapy and is currently evaluated in clinical trials. The aim of the present study was to further investigate the effects of an anti-angiogenic therapy, inhibiting vascular endothelial growth factor (VEGF) and endothelial growth factor (E...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2015
|
| In: |
Anticancer research
Year: 2015, Jahrgang: 35, Heft: 5, Pages: 2571-2576 |
| ISSN: | 1791-7530 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: http://ar.iiarjournals.org/content/35/5/2571
|
| Verfasserangaben: | Laura V. Klotz, Dirk-Andre Clevert, Siiri Scheckinger, Sebastian Strieth and Martin E. Eichhorn |
| Zusammenfassung: | Anti-angiogenic treatment is a promising strategy for cancer therapy and is currently evaluated in clinical trials. The aim of the present study was to further investigate the effects of an anti-angiogenic therapy, inhibiting vascular endothelial growth factor (VEGF) and endothelial growth factor (EGF) using a tyrosine kinase inhibitor for blocking tumor angiogenesis and tumor progression in vivo. |
|---|---|
| Beschreibung: | Gesehen am 08.07.2020 |
| Beschreibung: | Online Resource |
| ISSN: | 1791-7530 |